Verona is extending Ohtuvayre's life cycle through new formulations and fixed-dose combinations, aiming for cash flow ...

Verona Pharma (VRNA) has amended its existing strategic financing agreements by repaying the revenue interest purchase and sale agreement and ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

LONDON and RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a biopharmaceutical company focused on respiratory ...

Verona Pharma plc (NASDAQ:VRNA – Get Free Report)’s stock price gapped down before the market opened on Friday after an insider sold shares in the company. The stock had previously closed at $ ...

HC Wainwright increased their price target on shares of Verona Pharma from $60.00 to $75.00 and gave the stock a “buy” rating in a research report on Friday, February 28th.

On Friday, H.C. Wainwright analyst Raghuram Selvaraju increased the price target on Verona Pharma (NASDAQ:VRNA) to $75.00, up from ...

Investors with a lot of money to spend have taken a bearish stance on Verona Pharma (NASDAQ:VRNA). And retail traders should know. We noticed this today when the trades showed up on publicly ...